PharmaXcelerate - Building Resilient Pharma, Biotech Facilities & Quality Systems

PharmaXcelerate 2026 presented by TBM Group is a premier regional summit dedicated to advancing excellence in pharmaceutical and biotechnology facilities, manufacturing operations, and quality systems. Taking place from March 31 to April 2, 2026 in Dubai, United Arab Emirates, this event brings together senior executives, manufacturing and quality leaders, regulators, and solution providers shaping compliant and efficient pharma production in the Middle East and globally. The summit is structured around three core pillars: Engineering & Facility Design, focusing on digital transformation, cleanroom innovation, and sustainable operations; Manufacturing Excellence, emphasising process optimisation, technology transfer, and operational agility; and Quality & Compliance, covering GMP readiness, validation, and sterile manufacturing best practices.


Participants will gain insights from senior representatives of global pharma leaders such as Pfizer, AstraZeneca, Sanofi, GSK, Roche, Johnson & Johnson, Merck, Novartis, and Bayer, alongside regional innovators including Julphar, Hikma, SPIMACO, Riyadh Pharma, Jamjoom Pharma, Tabuk Pharmaceuticals, and Gulf Pharmaceutical Industries. The active involvement of local pharmaceutical authorities and regulatory agencies further enriches the dialogue, offering perspectives on national priorities, evolving standards, and regional market dynamics. PharmaXcelerate 2026 serves as a vital platform for collaboration, knowledge sharing, and strategic partnerships to build resilient, high-quality, and sustainable pharmaceutical and biotech manufacturing ecosystems.